Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study

Nav

General Info

Geography

Australia (AUS)

Austria (AUT)

Belgium (BEL)

Denmark (DNK)

Finland (FIN)

France (FRA)

Germany (DEU)

Greece (GRC)

Ireland (IRL)

Italy (ITA)

Netherlands (NLD)

New Zealand (NZL)

Norway (NOR)

Portugal (PRT)

Spain (ESP)

Sweden (SWE)

Switzerland (CHE)

United Kingdom (GBR)

View all

Time period covered

01/2000 - 12/2011

Data type

Scientific literature

Keywords

Chemotherapy, Health care costs, Multiple myeloma

Citation

Authors

Vogler S, Vitry A, Babar ZU

Journal

Lancet Oncol

Volume

Issue

Pages

39-47

Publication year

2016

Suggested citation

Vogler S, Vitry A, Babar ZU. Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study. Lancet Oncol. 2016; 17(1): 39-47.

DOI

10.1016/S1470-2045(15)00449-0

PMID

26670089

GHDx Entry last modified on: Mar 12, 2024

Header sites

Search form

Main menu

Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study

Nav